Page last updated: 2024-08-22

buthionine sulfoximine and Malignant Melanoma

buthionine sulfoximine has been researched along with Malignant Melanoma in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19904 (12.90)18.7374
1990's15 (48.39)18.2507
2000's7 (22.58)29.6817
2010's4 (12.90)24.3611
2020's1 (3.23)2.80

Authors

AuthorsStudies
Buettner, GR; Fath, MA; Gnade, CM; Goswami, PC; Hedlund, DK; Kloepping, KC; Kraus, AS; Lim, TH; McCormick, ML; Pigge, FC; Schultz, MK; Seol, D; Spitz, DR; Wagner, BA1
Campana, LG; De Mattei, M; De Terlizzi, F; Ongaro, A; Pellati, A; Rossi, CR1
Fortunato, RS; Kajitani, GS; Menck, CF; Quinet, A; Rocha, CR1
Barna, G; Magyar, K; Szende, B1
Castellani, P; Ciriolo, MR; Delfino, L; Lucibello, M; Rubartelli, A; Venè, R1
Doñate, F; Fruehauf, JP; Lee, K; Mazar, AP; Trapp, V1
Buckmeier, JA; Cen, D; Gonzalez, RI; Kahlon, RS; Meyskens, FL; Tohidian, NB1
Dubois, J; Duez, P; Ghanem, G; Kinnaert, E; Morandini, R; Van Houtte, P1
Abdel-Wahab, O; Cheng, TY; Friedman, HS; Grubbs, EG; Michael Colvin, O; Pruitt, SK; Tyler, DS; Ueno, T1
Cupissol, D; Cuq, P; Depeille, P; Evrard, A; Passagne, I; Vian, L1
del Marmol, V; Ghanem, G; Huez, G; Lejeune, F; Libert, A; Sels, A; Solano, F1
Bloomer, WD; Damodaran, KM; Prezioso, JA; Wang, N1
Bolognia, JL; Osber, MP; Pawelek, JM; Sodi, SA1
Benathan, M2
Creaven, PJ; Pendyala, L; Perez, R; Weinstein, A; Zdanowicz, J1
al-Bassam, M; Buzaid, AC; Dasgupta, C; Fruehauf, JP; Kyshtoobayeva, A; Milovanovic, T; Parker, RJ; Zonis, S2
Arstrand, K; Dizdar, N; Kågedal, B; Kullman, A1
Buckmeier, JA; McNulty, SE; Meyskens, FL; Tohidian, NB1
Benathan, M; Furumura, M; Hearing, VJ; Kobayashi, N; Panizzon, RG; Virador, V1
Dizdar, N; Kågedal, B; Kullman, A1
Bäumer, AT; Hescheler, J; Ling, FC; Petrat, K; Sauer, H; Schallenberg, M; Wartenberg, M1
Alvero-Jackson, H; Benathan, M; Frenk, E; Mooy, AM; Scaletta, C1
Guenthner, TM; Jevtović-Todorović, V1
FitzGerald, GB; Prezioso, JA; Wick, MM1
Bloomer, WD; Epperly, MW; Prezioso, JA; Wang, N1
Brötell, H; Karg, E; Rorsman, H; Rosengren, E1
Favier, D; Kable, EP; Parsons, PG1
Edgren, M; Ehrsson, H; Hansson, J; Nilsson, B; Ringborg, U1
Guichard, M; Lespinasse, F; Malaise, EP1

Other Studies

31 other study(ies) available for buthionine sulfoximine and Malignant Melanoma

ArticleYear
Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Animals; Auranofin; Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Synergism; Female; Humans; Hydrogels; Melanoma; Mice; Mitochondria; Organophosphorus Compounds; Oxidative Stress; Structure-Activity Relationship; Temperature; Xenograft Model Antitumor Assays

2020
Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells.
    Anti-cancer drugs, 2015, Volume: 26, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Electroporation; Glutathione; Humans; Melanoma; Melphalan

2015
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells.
    Oncotarget, 2016, Jul-26, Volume: 7, Issue:30

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Buthionine Sulfoximine; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Female; Glioma; Glutathione; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; NF-E2-Related Factor 2; Temozolomide; Xenograft Model Antitumor Assays

2016
Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.
    Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:6

    Topics: Amphetamines; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cytoprotection; Drug Interactions; Flow Cytometry; Glutathione; Humans; Melanoma; Monoamine Oxidase Inhibitors; Radiation-Sensitizing Agents; Selegiline; Serum

2010
The cystine/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets.
    Antioxidants & redox signaling, 2011, Nov-01, Volume: 15, Issue:9

    Topics: Antioxidants; Arsenic Trioxide; Arsenicals; Blotting, Western; Buthionine Sulfoximine; Cell Survival; Cysteine; Cystine; Glutathione; Glycine; HMGB1 Protein; Humans; Immunohistochemistry; Melanoma; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Tumor Cells, Cultured

2011
Redox-related antimelanoma activity of ATN-224.
    Melanoma research, 2009, Volume: 19, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Disulfiram; Drug Synergism; Enzyme Inhibitors; Glutathione; Humans; Melanins; Melanoma; Molybdenum; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Superoxide Dismutase; Temozolomide

2009
Disulfiram induces apoptosis in human melanoma cells: a redox-related process.
    Molecular cancer therapeutics, 2002, Volume: 1, Issue:3

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Buthionine Sulfoximine; Cell Division; Disulfiram; Enzyme Inhibitors; Glutathione; Melanocytes; Melanoma; Membrane Potentials; Mitochondria; Neoplasm Metastasis; Oxidative Stress; Reactive Oxygen Species; Tumor Cells, Cultured

2002
Cysteine but not glutathione modulates the radiosensitivity of human melanoma cells by affecting both survival and DNA damage.
    Pigment cell research, 2004, Volume: 17, Issue:3

    Topics: Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Comet Assay; Cysteine; DNA Damage; Dose-Response Relationship, Radiation; Glutathione; Humans; Melanoma; Pigmentation; Radiation Tolerance; Radiation-Sensitizing Agents

2004
Modulation of resistance to regional chemotherapy in the extremity melanoma model.
    Surgery, 2004, Volume: 136, Issue:2

    Topics: Animals; Buthionine Sulfoximine; Chemotherapy, Cancer, Regional Perfusion; Drug Resistance, Neoplasm; Female; Glutathione; Melanoma; Melphalan; Rats

2004
O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C.
    Toxicology and applied pharmacology, 2006, Mar-01, Volume: 211, Issue:2

    Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Inhibitory Concentration 50; Melanoma; Mitomycin; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temozolomide; Transfection

2006
Glutathione depletion increases tyrosinase activity in human melanoma cells.
    The Journal of investigative dermatology, 1993, Volume: 101, Issue:6

    Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Glutathione; Humans; Melanins; Melanoma; Methionine Sulfoximine; Monophenol Monooxygenase; Sulfhydryl Compounds; Time Factors; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase

1993
Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
    Biochemical pharmacology, 1993, Jan-26, Volume: 45, Issue:2

    Topics: Animals; Biotransformation; Buthionine Sulfoximine; Cell Division; Glutamine; Glutathione; GTP Phosphohydrolases; Humans; Melanins; Melanoma; Methionine Sulfoximine; Mice; Monophenol Monooxygenase; Oxidation-Reduction; Phenols; Protein Precursors; Tetrazolium Salts; Thiazoles; Thymidylate Synthase; Tumor Cells, Cultured

1993
Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine.
    The British journal of dermatology, 1995, Volume: 133, Issue:3

    Topics: Animals; Buthionine Sulfoximine; Cystamine; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Guinea Pigs; Hair Color; Hydroquinones; Melanoma; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Skin Pigmentation; Tumor Cells, Cultured

1995
Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.
    Melanoma research, 1996, Volume: 6, Issue:3

    Topics: Buthionine Sulfoximine; Catechols; Cell Line; Cysteine; Cysteinyldopa; Glutathione; Humans; Melanoma; Microscopy, Electron; Monophenol Monooxygenase; Tumor Cells, Cultured

1996
Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:1

    Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Survival; Cisplatin; Glutathione; Humans; Melanoma; Organoplatinum Compounds; Tumor Cells, Cultured

1997
Opposite regulation of tyrosinase and glutathione peroxidase by intracellular thiols in human melanoma cells.
    Archives of dermatological research, 1997, Volume: 289, Issue:6

    Topics: Buthionine Sulfoximine; Carmustine; Cysteine; Cystine; Glutathione; Glutathione Peroxidase; Humans; Melanins; Melanoma; Monophenol Monooxygenase; Oxidative Stress; Sodium Selenite; Sulfhydryl Compounds; Tumor Cells, Cultured

1997
Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase.
    Pigment cell research, 1997, Volume: 10, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Breast Neoplasms; Buthionine Sulfoximine; Carmustine; Drug Synergism; Female; Glutathione; Glutathione Transferase; Humans; Melanins; Melanoma; Ovarian Neoplasms; Tumor Cells, Cultured

1997
Effects on interstitial glutathione, cysteine and 5-S-cysteinyldopa of buthionine sulphoximine in human melanoma transplants.
    Melanoma research, 1997, Volume: 7, Issue:4

    Topics: Acetylcysteine; Animals; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cysteine; Cysteinyldopa; Drug Interactions; Enzyme Inhibitors; Glutathione; Humans; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Microdialysis; Neoplasm Transplantation; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines

1997
Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Chemico-biological interactions, 1998, Apr-24, Volume: 111-112

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buthionine Sulfoximine; Carmustine; Down-Regulation; Drug Resistance; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Glutathione Transferase; Humans; Melanins; Melanoma; Melphalan; Ovarian Neoplasms; Tumor Cells, Cultured

1998
Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5

    Topics: Buthionine Sulfoximine; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; I-kappa B Proteins; Melanocytes; Melanoma; Neoplasm Metastasis; Neoplasm Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidation-Reduction; Oxidative Stress; Protein Isoforms; Transcription Factor AP-1; Tumor Cells, Cultured

1999
Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
    Cellular and molecular biology (Noisy-le-Grand, France), 1999, Volume: 45, Issue:7

    Topics: Buthionine Sulfoximine; Cells, Cultured; Cysteine; Cysteinyldopa; Dihydroxyphenylalanine; Glutathione; Humans; Infant, Newborn; Male; Melanins; Melanocytes; Melanoma; Melanosomes; Monophenol Monooxygenase; Neoplasm Proteins; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine

1999
Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice.
    Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:3

    Topics: Acetylcysteine; Animals; Buthionine Sulfoximine; Cysteine; Cysteinyldopa; Enzyme Inhibitors; Glutathione; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Microdialysis; Neoplasm Transplantation; Protein Precursors; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Transplantation, Heterologous; Tumor Cells, Cultured

2000
Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species.
    The Journal of biological chemistry, 2001, May-18, Volume: 276, Issue:20

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Drug Resistance, Multiple; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Kinetics; Liver Neoplasms; Male; MAP Kinase Signaling System; Melanoma; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein-Tyrosine Kinases; Reactive Oxygen Species; Tumor Cells, Cultured; Tumor Suppressor Proteins

2001
Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
    Melanoma research, 1992, Volume: 2, Issue:5-6

    Topics: Bucladesine; Buthionine Sulfoximine; Cell Differentiation; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Eye Neoplasms; Glutathione; Glutathione Transferase; Humans; Kinetics; Melanins; Melanoma; Melphalan; Methionine Sulfoximine; Microscopy, Electron; Monophenol Monooxygenase; Neoplasm Staging; Skin Neoplasms; Tumor Cells, Cultured

1992
Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro.
    Biochemical pharmacology, 1992, Oct-06, Volume: 44, Issue:7

    Topics: Buthionine Sulfoximine; Carmustine; Cell Division; Cell Nucleus; Cytosol; Doxorubicin; Drug Synergism; Glutathione; Glutathione Disulfide; Humans; Melanoma; Melphalan; Methionine Sulfoximine; Oxidation-Reduction; Tumor Cells, Cultured

1992
Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.
    The Journal of investigative dermatology, 1992, Volume: 99, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Dopamine; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Melanoma; Melanoma, Experimental; Melphalan; Methionine Sulfoximine; Mice; Tumor Cells, Cultured

1992
Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
    Cancer letters, 1992, Mar-31, Volume: 63, Issue:1

    Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cysteamine; Drug Synergism; Humans; Melanoma; Methionine Sulfoximine; Monophenol Monooxygenase; Phenols; Theophylline; Time Factors; Tumor Cells, Cultured

1992
Modulation of glutathione level in cultured human melanoma cells.
    Acta dermato-venereologica, 1989, Volume: 69, Issue:2

    Topics: Antimetabolites; Buthionine Sulfoximine; Cell Line; Cell Survival; Cysteine; Glutathione; Humans; Melanoma; Methionine Sulfoximine; Tumor Cells, Cultured; Vitamin K

1989
Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Cancer research, 1989, May-01, Volume: 49, Issue:9

    Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Glutathione; Humans; Levodopa; Melanoma; Methionine Sulfoximine; Tumor Cells, Cultured

1989
Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Cancer research, 1988, Jan-01, Volume: 48, Issue:1

    Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Division; Cell Survival; Cross-Linking Reagents; DNA; Drug Synergism; Glutathione; Humans; Melanoma; Melphalan; Methionine Sulfoximine; Tumor Cells, Cultured

1988
Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Radiation research, 1986, Volume: 105, Issue:1

    Topics: Adenocarcinoma; Animals; Buthionine Sulfoximine; Cell Line; Colonic Neoplasms; Female; Glutathione; Humans; Melanoma; Methionine Sulfoximine; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms; Radiation Tolerance; Transplantation, Heterologous

1986